GlassScriptPhysician profile
Melissa Wren
NPI 1528482759
$10,452.50
in general payments reported to CMS, 2019-2025
48 companies · $397 in 2025
The $397 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,250 · 2022: $3,830 · 2023: $4,347 · 2024: $629 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,320 · Education: $53.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,319.82 |
| Education | $53.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,637.94 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $976.79 | 2021-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Biogen, INC. | $520.30 | 2021-2023 | Vumerity, Tysabri, Plegridy |
| Otsuka America Pharmaceutical, INC. | $506.70 | 2023-2024 | Rexulti, Nuedexta |
| E.R. Squibb & Sons, L.L.C. | $475.09 | 2022-2025 | Cobenfy |
| Emd Serono, INC. | $398.23 | 2022-2023 | Mavenclad |
| Mdd US Operations, LLC | $350.22 | 2021-2024 | Apokyn, Apokyn |
| Biohaven Pharmaceutical Holding Company LTD. | $346.03 | 2022 | |
| Lilly USA, LLC | $318.22 | 2021-2023 | Reyvow, Emgality, Amyvid |
| Lundbeck LLC | $304.10 | 2021-2023 | Vyepti, Rexulti |
| Sk Life Science, INC. | $291.21 | 2021-2023 | |
| Neurocrine Biosciences, INC. | $283.08 | 2022-2023 | Ongentys, Ingrezza |
| Acadia Pharmaceuticals INC | $279.52 | 2022-2023 | Nuplazid |
| Celgene Corporation | $275.66 | 2022-2023 | Zeposia |
| Medtronic, INC. | $265.60 | 2022-2023 | Percept PC Brainsense, Activa PC |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Wren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.